BIOMARKERS FOR SENSITIVITY TO ANTI-IGF1R THERAPY

摘要

The present invention provides, for example, methods for conveniently determining if a cancerous condition in a subject will be responsive to an IGF1R inhibitor. The invention includes patient selection methods and methods of treatment.